Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
CONTEXT: Appropriate glucocorticoid replacement therapy in adrenal insufficiency (AI) is crucial, given the risks of chronic under- or overtreatment, particularly in patients on multiple medications. Salivary sampling allows for non-invasive, stress-free cortisol measurement. OBJECTIVE: To determine whether salivary cortisol measurement is helpful in assessing the adequacy of glucocorticoid therapy with cortisone acetate (CA) in patients with secondary AI. DESIGN: A prospective cohort study at the Endocrinology Unit of Padua University Hospital. METHODS: Six samples of salivary cortisol were collected from 28 patients with secondary AI on CA treatment and from 36 healthy volunteers at fixed times of the day, and used to calculate salivary cortisol levels at each time point and the area under the curve (AUC) across the different sampling times. RESULTS: Salivary cortisol levels were lower in patients than in controls in the morning but no differences were found in the afternoon or at night before resting. Salivary cortisol levels were higher in patients immediately following CA administration. Ten patients showed an AUC above the 97.5th percentile of controls, without clinical signs of hypercortisolism, and salivary cortisol levels 90 min after each dose of CA predict the AUC. All patients had severe GH deficiency and there were no differences in salivary cortisol levels or AUC between patients treated or not with GH. CONCLUSIONS: Two salivary cortisol determinations, able to predict the daily AUC, may allow for assessing the adequacy of glucocorticoid replacement therapy in secondary AI and for identifying cases of over- or undertreatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 1×
“Since a normal night-time cortisol value excludes hypercortisolism (32), the F 14 salivary cortisol could be a useful marker of glucocorticoid excess in AI.”
Ho, K. K. Y., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0631 · Cited by 615
Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis
Kazlauskaite, R., Evans, A. T., Villabona, C. V., Abdu, T. A. M., Ambrosi, B., Atkinson, A. B., Choi, C. H., Clayton, R. N., Courtney, C. H., Gonc, E. N., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0710 · Cited by 385 · cited 1×
“patients or inadequate cortisol response (considered as cortisol below 440 nmol/l) to a standard or low-dose ACTH test (25) in the other 16 subjects), and the patients had been taking the same CA replacement dose for at least 6 months before enrollment.”
Johannsson, G., Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, O., Ryberg, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1926 · Cited by 329 · cited 1×
“The modern once-daily HC dual-release tablet probably achieved a cortisol profile more similar to healthy subjects, but there is less evidence and was found only in primary AI patients treated with this therapy (31).”
Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321 · cited 2×
“exposure in patients treated with CA or HC in association with rhGH therapy, which inhibits the metabolism of cortisone into cortisol (8, 9, 23).”
Long‐term stability of salivary cortisol
Garde, A. H., & Hansen, Å. M. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510510025773 · Cited by 260 · cited 2×
“Salivary steroids are a non-invasive, easily repeated, stress-free way to measure circulating free hormone levels (12, 13), recently recommended for assessing cortisol profiles in healthy people (14, 15) and in patients with hypothalamic–pituitary–adrenal (HPA) axis disorders (16, 17).”
Mah, P. M., Jenkins, R. C., Rostami‐Hodjegan, A., Newell‐Price, J., Doane, A., Ibbotson, V., Tucker, G. T., & Ross, R. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02106.x · Cited by 243 · cited 6×
“Optimal replacement should produce cortisol concentrations that mirror the circadian cortisol rhythm (2), but available immediate-release glucocorticoid preparations only partially replicate the physiological cortisol profile (3); expertise with modified-release hydrocortisone (HC) tablets is still inadequate (4, 5).”
InfluentialUtility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency
Raff, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1166 · Cited by 186
Verma, S., VanRyzin, C., Sinaii, N., Kim, M. S., Nieman, L. K., Ravindran, S., Calis, K. A., Arlt, W., Ross, R. J., & Merke, D. P. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03636.x · Cited by 126
Deutschbein, T., Broecker-Preuss, M., Flitsch, J., Jaeger, A., Althoff, R., Walz, M. K., Mann, K., & Petersenn, S. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0945 · Cited by 81 · cited 2×
“(17), even though a few of our patients have some residual glucocorticoid activity, as expected in secondary AI.”
Cited by
The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids
Oster, H., Challet, E., Ott, V., Arvat, E., de Kloet, E. R., Dijk, D.-J., Lightman, S., Vgontzas, A., & Van Cauter, E. (2017) · Endocrine Reviews · doi:10.1210/er.2015-1080 · Cited by 548
“Therefore, biochemical monitoring in the form of blood (407) or salivary cortisol (408)”
Salivary cortisol and cortisone in the clinical setting
Blair, J., Adaway, J., Keevil, B., & Ross, R. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000328 · Cited by 138
Debono, M., Harrison, R. F., Whitaker, M. J., Eckland, D., Arlt, W., Keevil, B. G., & Ross, R. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3694 · Cited by 128
“The use of two salivary cortisol samples, measured 1 hour and 30 minutes after cortisone acetate, as an indication of 24-hour cortisol exposure has been suggested but this does not give an indication of fluctuating changes (27).”
MethodAntonelli, G., Ceccato, F., Artusi, C., Marinova, M., & Plebani, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.004 · Cited by 111
Self-citationCeccato, F., Barbot, M., Zilio, M., Ferasin, S., Occhi, G., Daniele, A., Mazzocut, S., Iacobone, M., Betterle, C., Mantero, F., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0159 · Cited by 75
Self-citation
Metadata
- Authors
- Ceccato, F., Albiger, N., Reimondo, G., Frigo, A. C., Ferasin, S., Occhi, G., Mantero, F., Terzolo, M., & Scaroni, C.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10-03
- Volume
- 167
- Issue
- 6
- Pages
- 769-776
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2098139368
- Cited by
- 35
- References
- 10
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. https://app.cochat.ai/papers/10.1530/eje-12-0534
- The paper
- Ceccato, F., Albiger, N., Reimondo, G., Frigo, A. C., Ferasin, S., Occhi, G., Mantero, F., Terzolo, M., & Scaroni, C. (2012). Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. European Journal of Endocrinology. https://doi.org/10.1530/eje-12-0534
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.